29 июл 2020 г. - The FDA grants Truvian the first EUA for a rapid antibody test. The company reported a sensitivity rate of 98.44% (very low % of false negatives) and a specificity rate of 98.9% (very low % of false positive).

Добавлено на ленту времени:

COVID 2020 - Policy, vaccines, therapies, and testing

ByMedicalGold.ca

16 сен 2021

0

0

590

Дата: